NDC 0469-0687

ASTAGRAF XL

Tacrolimus Extended-release Capsules

ASTAGRAF XL is a Oral Capsule, Coated, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Astellas Pharma Us, Inc.. The primary component is Tacrolimus.

Product ID0469-0687_4b0d99f4-01fe-47b4-a447-70c996917f4a
NDC0469-0687
Product TypeHuman Prescription Drug
Proprietary NameASTAGRAF XL
Generic NameTacrolimus Extended-release Capsules
Dosage FormCapsule, Coated, Extended Release
Route of AdministrationORAL
Marketing Start Date2013-07-19
Marketing CategoryNDA / NDA
Application NumberNDA204096
Labeler NameAstellas Pharma US, Inc.
Substance NameTACROLIMUS
Active Ingredient Strength5 mg/1
Pharm ClassesCalcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 0469-0687-11

5 BLISTER PACK in 1 CARTON (0469-0687-11) > 10 CAPSULE, COATED, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Start Date2013-07-19
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0469-0687-73 [00469068773]

ASTAGRAF XL CAPSULE, COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA204096
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2013-07-19

NDC 0469-0687-11 [00469068711]

ASTAGRAF XL CAPSULE, COATED, EXTENDED RELEASE
Marketing CategoryNDA
Application NumberNDA204096
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2013-07-19
Marketing End Date2019-06-24

Drug Details

Active Ingredients

IngredientStrength
TACROLIMUS5 mg/1

OpenFDA Data

SPL SET ID:550a5cd4-fbf2-4c09-b577-6bde8fcbdf6e
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1431971
  • 1431977
  • 1431987
  • 1431985
  • 1431982
  • 1431980
  • Pharmacological Class

    • Calcineurin Inhibitor Immunosuppressant [EPC]
    • Calcineurin Inhibitors [MoA]

    NDC Crossover Matching brand name "ASTAGRAF XL" or generic name "Tacrolimus Extended-release Capsules"

    NDCBrand NameGeneric Name
    0469-0647ASTAGRAF XLtacrolimus extended-release capsules
    0469-0677ASTAGRAF XLtacrolimus extended-release capsules
    0469-0687ASTAGRAF XLtacrolimus extended-release capsules

    Trademark Results [ASTAGRAF XL]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    ASTAGRAF XL
    ASTAGRAF XL
    85925271 4480263 Live/Registered
    Astellas Pharma Inc.
    2013-05-07

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.